Expression of urokinase plasminogen activator and the urokinase plasminogen activator receptor in myeloma cells

British Journal of Haematology

Volumn 109, Issue 4, 2000, Pages 815-822

  Hjertner, Öyvind ^a   Qvigstad, Gunnar ^a   Hjorth Hansen, Henrik ^a   Seidel, Carina ^a   Woodliff, Jeffery ^b   Epstein, Joshua ^b   Waage, Anders ^c   Sundan, Anders ^a   Börset, Magne ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

CD45; Myeloma cells; uPA; uPA receptor

Indexed keywords

CD45 ANTIGEN; UROKINASE; UROKINASE RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; BONE MATRIX; CANCER CELL CULTURE; CANCER INVASION; CELL INVASION; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MYELOMA; MYELOMA CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; RECEPTOR BINDING;

FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MULTIPLE MYELOMA; PLASMINOGEN ACTIVATORS; RECEPTORS, CELL SURFACE; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

EID: 0033859145     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02089.x     Document Type: Article

References (51)

1. Andreasen, P.A., Kjoller, L., Christensen, L. & Duffy, M.J. (1997) The urokinase-type plasminogen activator system in cancer metastasis: a review. International Journal of Cancer, 72, 1-22.
2. Barille, S., Akhoundi, C., Collette, M., Mellerin, M.P., Rapp, M.J., Harousseau, J.L., Bataille, R. & Amiot, M. (1997) Metalloproteinases in multiple myeloma: production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells. Blood, 90, 1649-1655.
3. Blasi, F. (1997) uPA, uPAR, PAI-1: key intersection of proteolytic, adhesive and chemotactic highways? Immunology Today, 18, 415-417.
4. Börset, M., Waage, A., Brekke, O.L. & Helseth, E. (1994) TNF and IL-6 are potent growth factors for OH-2, a novel human myeloma cell line. European Journal of Haematology, 53, 31-37.
5. Börset, M., Hjorth-Hansen, H., Seidel, C., Sundan, A. & Waage, A. (1996) Hepatocyte growth factor and its receptor c-met in multiple myeloma. Blood, 88, 3998-4004.
6. Campbell, P.G., Novak, J.F., Yanosick, T.B. & McMaster, J.H. (1992) Involvement of the plasmin system in dissociation of the insulin-like growth factor-binding protein complex. Endocrinology, 130, 1401-1412.
7. Carmeliet, P., Moons, L., Lijnen, R., Baes, M., Lemaitre, V., Tipping, P., Drew, A., Eeckhout, Y., Shapiro, S., Lupu, F. & Collen, D. (1997) Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nature Genetics, 17, 439-444.
8. Chapman, H.A. (1997) Plasminogen activators, integrins, and the co-ordinated regulation of cell adhesion and migration. Current Opinion in Cell Biology, 9, 714-724.
9. Daci, E., Udagawa, N., Martin, T.J., Bouillon, R. & Carmeliet, G. (1999) The role of the plasminogen system in bone resorption in vitro. Journal of Bone and Mineral Research, 14, 946-952.
10. Dano, K., Andreasen, P.A., Grondahl-Hansen, J., Kristensen, P., Nielsen, L.S. & Skriver, L. (1985) Plasminogen activators, tissue degradation, and cancer. Advances in Cancer Research, 44, 139-266.
11. Donate, L.E., Gherardi, E., Srinivasan, N., Sowdhamini, R., Aparicio, S. & Blundell, T.L. (1994) Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP). Protein Science, 3, 2378-2394.
12. Hallek, M., Bergsagel, P.L. & Anderson, K.C. (1998) Multiple myeloma: increasing evidence for a multistep transformation process. Blood, 91, 3-21.
13. Hannocks, M.J., Oliver, L., Gabrilove, J.L. & Wilson, E.L. (1992) Regulation of proteolytic activity in human bone marrow stromal cells by basic fibroblast growth factor, interleukin-1, and transforming growth factor beta. Blood, 79, 1178-1184.
14. Hata, H., Xiao, H., Petrucci, M.T., Woodliff, J., Chang, R. & Epstein, J. (1993) Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumour cells. Blood, 81, 3357-3364.
15. Hjertner, O., Torgersen, M.L., Seidel, C., Hjorth-Hansen, H., Waage, A., Borset, M. & &. Sundan, A. (1999) Hepatocyte growth factor (HGF) induces interleukin-11 secretion from osteoblasts: a possible role for HGF in myeloma-associated osteolytic bone disease. Blood, 94, 3883-3888.
16. Hoekman, K., Lowik, C.W, Ruit, v d M., Bijvoet, O.L., Verheijen, J.H. & Papapoulos, S.E. (1991) Regulation of the production of plasminogen activators by bone resorption enhancing and inhibiting factors in three types of osteoblast-like cells. Bone and Mineral, 14, 189-204.
17. Holst-Hansen, C., Johannessen, B., Hoyer-Hansen, G., Romer, J., Ellis, V. & Brunner, N. (1996) Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness. Clinical and Experimental Metastasis, 14, 297-307.
18. Jackson, N., Lowe, J., Ball, J., Bromidge, E., Ling, N.R., Larkins, S., Griffith, M.J. & Franklin, I.M. (1989) Two new IgA1-kappa plasma cell leukaemia cell lines (JJN-1 & JJN-2) which proliferate in response to B cell stimulatory factor 2. Clinical and Experimental Immunology, 75, 93-99.
19. Jardi, M., Ingles-Esteve, J., Burgal, M., Azqueta, C., Velasco, F., Lopez-Pedrera, C., Miles, L.A. & Felez, J. (1996) Distinct patterns of urokinase receptor (uPAR) expression by leukemic cells and peripheral blood cells. Thrombosis and Haemostasis, 76,1009-1019.
20. Jones, P.A. & DeClerck, Y.A. (1980) Destruction of extracellular matrices containing glycoproteins, elastin, and collagen by metastatic human tumour cells. Cancer Research, 40, 3222-3227.
21. Joshua, D., Petersen, A., Brown, R., Pope, B., Snowdon, L. & Gibson, J. (1996) The labelling index of primitive plasma cells determines the clinical behaviour of patients with myelomatosis. British Journal of Haematology, 94, 76-81.
22. Kiener, P.A., Davis, P.M., Rankin, B.M., Klebanoff, S.J., Ledbetter, J.A., Starling, G.C. & Liles, W.C. (1997) Human monocytic cells contain high levels of intracellular Fas ligand. Journal of Immunology, 159, 1594-1598.
23. Klein, B. (1995) Cytokine, cytokine receptors, transduction signals, and oncogenes in human multiple myeloma. Seminars in Hematology, 32, 4-19.
24. Kobayashi, H., Ohi, H., Sugimura, M., Shinohara, H., Fujii, T. & Terao, T. (1992) Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B. Cancer Research, 52, 3610-3614.
25. Lanza, F., Castoldi, G.L., Castagnari, B., Todd, 3rd, R.F., Moretti, S., Spisani, S., Latorraca, A., Focarile, E., Roberti, M.G. & Traniello, S. (1998) Expression and functional role of urokinase-type plasminogen activator receptor in normal and acute leukaemic cells. British Journal of Haematology, 103, 110-123.
26. Liotta, L.A., Goldfarb, R.H., Brundage, R., Siegal, G.P., Terranova, V. & Garbisa, S. (1981) Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Research, 41, 4629-4636.
27. Lokhorst, H.M., Lamme, T., de Smet, M., Klein, S., de Weger, R.A., van Oers, R. & Bloem, A.C. (1994) Primary tumour cells of myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures. Blood, 84, 2269-2277.
28. Lyons, R.M., Gentry, L.E., Purchio, A.F. & Moses, H.L. (1990) Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin. Journal of Cell Biology, 110, 1361-1367.
29. Mahmoud, M.S., Ishikawa, H., Fujii, R. & Kawano, M.M. (1998) Induction of CD45 expression and proliferation in U-266 myeloma cell line by interleukin-6. Blood, 92, 3887-3897.
30. Mars, W.M., Zarnegar, R. & Michalopoulos, G.K. (1993) Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. American Journal of Pathology, 143, 949-958.
31. Mignatti, P., Robbins, E. & Rifkin, D.B. (1986) Tumour invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell, 47, 487-498.
32. Miyazawa, K., Shimomura, T., Kitamura, A., Kondo, J., Morimoto, Y. & Kitamura, N. (1993) Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor. Structural similarity of the protease precursor to blood coagulation factor XII. Journal of Biological Chemistry, 268, 10024-10028.
33. Moore, G.E. & Kitamura, H. (1968) Cell line derived from patient with myeloma. New York State Journal of Medicine, 68, 2054-2060.
34. Naldini, L., Vigna, E., Bardelli, A., Follenzi, A., Galimi, F. & Comoglio, P.M. (1995) Biological activation of pro-HGF (hepatocyte growth factor) by urokinase is controlled by a stoichiometric reaction. Journal of Biological Chemistry, 270, 603-611.
35. Nilsson, K., Bennich, H., Johansson, S.G. & Ponten, J. (1970) Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient. Clinical and Experimental Immunology, 7, 477-489.
36. O'Grady, R.L., Upfold, L.I. & Stephens, R.W. (1981) Rat mammary carcinoma cells secrete active collagenase and activate latent enzyme in the stroma via plasminogen activator. International Journal of Cancer, 28, 509-515.
37. Ossowski, L. (1988) Plasminogen activator dependent pathways in the dissemination of human tumour cells in the chick embryo. Cell, 52, 321-328.
38. Paar, D. & Maruhn, D. (1980) Spectrometric determination of urokinase in urine after gel filtration, using the chromogenic substrate S-2444. Journal of Clinical Chemistry and Clinical Biochemistry, 18, 557-562.
39. Paysant, J., Vasse, M., Soria, J., Lenormand, B., Pourtau, J., Vannier, J.P. & Soria, C. (1998) Regulation of the uPAR/uPA system expressed on monocytes by the deactivating cytokines, IL-4, IL-10 and IL-13: consequences on cell adhesion to vitronectin and fibrinogen. British Journal of Haematology, 100, 45-51.
40. Plesner, T., Ploug, M., Ellis, V., Ronne, E., Hoyer-Hansen, G., Wittrup, M., Pedersen, T.L., Tscherning, T., Dano, K. & Hansen, N.E. (1994a) The receptor for uPA-type plasminogen activator and urokinase is translocated from two distinct intracellular compartments to the plasma membrane on stimulation of human neutrophils. Blood, 83, 808-815.
41. Plesner, T., Ralfkiaer, E., Wittrup, M., Johnsen, H., Pyke, C., Pedersen, T.L., Hansen, N.E. & Dano, K. (1994b) Expression of the receptor for urokinase-type plasminogen activator in normal and neoplastic blood cells and hematopoietic tissue. American Journal of Clinical Pathology, 102, 835-841.
42. Ploug, M., Behrendt, N., Lober, D. & Dano, K. (1991) Protein structure and membrane anchorage of the cellular receptor for urokinase-type plasminogen activator. Seminars in Thrombosis and Hemostasis, 17, 183-193.
43. Schneider, U., van Lessen, A., Huhn, D. & Serke, S. (1997) Two subsets of peripheral blood plasma cells defined by differential expression of CD45 antigen. British Journal of Haematology, 97, 56-64.
44. Seiffert, D. (1996) Detection of vitronectin in mineralized bone matrix. Journal of Histochemistry and Cytochemistry, 44, 275-280.
45. Uchiyama, H., Barut, B.A., Mohrbacher, A.F., Chauhan, D. & Andersen, K.C. (1993) Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion. Blood, 82, 3712-3720.
46. Vacca, A., Ribatti, D., Presta, M., Minischetti, M., Iurlaro, M., Ria, R., Albini, A., Bussolino, F. & Dammacco, F. (1999) Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood, 93, 3064-3073.
47. Wei, Y, Waltz, D.A., Rao, N., Drummond, R.J., Rosenberg, S. & Chapman, H.A. (1994) Identification of the urokinase receptor as an adhesion receptor for vitronectin. Journal of Biological Chemistry, 269, 32380-32388.
48. Wei, Y., Lukashev, M., Simon, D.I., Bodary, S.C., Rosenberg, S., Doyle, M.V. & Chapman, H.A. (1996) Regulation of integrin function by the urokinase receptor. Science, 273, 1551-1555.
49. Werb, Z., Mainardi, C.L., Vater, C.A. & Harris, F.D. (1977) Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator. New England Journal of Medicine, 296, 1017-1023.
50. Xing, R.H. & Rabbani, S.A. (1996) Overexpression of urokinase receptor in breast cancer cells results in increased tumour invasion, growth and metastasis. International Journal of Cancer, 67, 423-429.
51. Yebra, M., Goretzki, L., Pfeifer, M. & Mueller, B.M. (1999) Urokinase-type plasminogen activator binding to its receptor stimulates tumour cell migration by enhancing integrin-mediated signal transduction. Experimental Cell Research, 250, 231-240.